About MaryRose Cusimano-Reaston
Form D filings for Emerge Diagnostics in 2019 list MaryRose Cusimano-Reaston as chief executive officer.
MaryRose Cusimano-Reaston first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name MaryRose Cusimano-Reaston in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people MaryRose Cusimano-Reaston works with at each company, as listed on that company's latest Form D.
Emerge Diagnostics, Inc. · Form D, Dec 31, 2019
MC
Michael Connor
Director
MS
Mark Sampson
Director
ML
Murray Lappe
Director
GW
Greer Woodruff
Director
TW
Thomas Webster
Director
PR
Phil Reaston
Executive officer
RT
Robert Thompson
Director